Welcome to Caremark Ulysses Holding Corp. By opting in to our messaging services, you agree to the following terms and conditions:
Service Overview Caremark Ulysses Holding Corp provides genetic screening services to Medicare beneficiaries, offering tests that identify hereditary risks for conditions such as cancer, neurocognitive disorders, or autoimmune diseases. By opting in, you consent to receive SMS communications related to test eligibility, appointment scheduling, and results.
Message Frequency You may receive multiple messages per month. These messages will include details on test availability, eligibility updates, and relevant information regarding your participation in our genetic screening programs.
Opt-In and Opt-Out:
By submitting your phone number via our website, you opt-in to receive messages from Caremark Ulysses Holding Corp.
To opt-out at any time, reply "STOP" to any message you receive from us. After opting out, you will no longer receive SMS communications, except for confirmation of your opt-out request.
Data Privacy and Security:
We are committed to maintaining the privacy of your information. All personal data collected, including your phone number and health information, is protected under HIPAA guidelines and will not be shared with third parties without your consent.
Cost of Messages:
Standard message and data rates may apply based on your mobile carrier plan. Caremark Ulysses Holding Corp is not responsible for any charges you incur from your carrier for receiving text messages from us.
No Medical Advice:
The messages you receive from Caremark Ulysses Holding Corp are for informational purposes only and do not constitute medical advice. For any medical concerns, please consult a healthcare professional.
Changes to Terms:
We reserve the right to modify these terms at any time. Continued use of our messaging services constitutes your acceptance of any such changes.
If you have any questions or require further assistance, please contact us at info@caremarkulyssesholdingcorp.site .
Disclaimer :
Caremark Ulysses Holding Corp. Inc dedicated to offering educational resources designed to facilitate discussions between consumers and their primary care providers, in collaboration with Health's genetic testing laboratory. Our objective is to enhance health and quality of life by providing top-tier diagnostic services and leveraging technology to improve the delivery of care. We are currently in the process of introducing a new and innovative solution and are working tirelessly to ensure the provision of the highest level of services and care. Medicare Part B recipients may be eligible for genetic testing as a benefit, as requested by their primary care provider. Additionally, many private insurance companies offer preventative genetic testing benefits.
6 INTERNATIONAL DRIVE SUITE #190 RYE BROOK, NY 10573-1068
info@caremarkulyssesholdingcorp.site